Enter the game-changing implant technology that’s transforming sleep apnea treatment. Two notable options have emerged: Genio Nyxoah and Inspire. These devices offer a novel approach to managing ...

WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...

CPAP is known as a treatment for sleep apnea syndrome, but not all patients are comfortable wearing it, and research has shown that 34.1% of people do not wear CPAP. The implant is intended for ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

TUPELO — For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough solution. Larry Ferguson, 77, of Pontotoc, is among those whose ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment, with FDA approval expected in Q1 2025 acting as a potential catalyst for shares. Nyxoah, founded by Robert Taub ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study ...